An Observational Prospective Study to Analyse Changes in the Klinrisk Chronic Kidney Disease Progression Model Score in a Cohort of Patients With CKD Associated With Type 2 Diabetes Treated With Finerenone in Spain
Latest Information Update: 05 Jun 2026
At a glance
- Drugs Finerenone (Primary)
- Indications Renal failure; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms FINEXPLORER
- Sponsors Bayer
Most Recent Events
- 26 May 2026 Planned initiation date changed from 30 Apr 2026 to 31 May 2026.
- 05 May 2026 New trial record